{
    "Clinical Trial ID": "NCT02635737",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Sentimark Device Placement",
        "  Sentimark device placed in women having mastectomy surgery",
        "  Sentimark: Placement of a metallic clip with paramagnetic properties for tumour localisation"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Participant is willing and able to give informed consent for participation in the study;",
        "  Female, aged 18 years or above;",
        "  Diagnosed with breast cancer (invasive or dcis);",
        "  Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study;",
        "  Undergoing mastectomy breast surgery.",
        "Exclusion Criteria:",
        "  Patients with a Pacemaker or implanted device;",
        "  Patients requiring an MRI scan prior to surgery;",
        "  Patients with known coagulopathy or receiving anticoagulant medication including warfarin, heparin, clopidogrel or rivaroxaban;",
        "  Patients receiving Neoadjuvant chemotherapy;",
        "  Patients who are pregnant or lactating;",
        "  Patients scheduled for immediate breast reconstruction;",
        "  Patients who have received Sienna (iron oxide) injection in the previous six months;",
        "  Patients with an existing breast haematoma close to the target lesion."
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Migration of Sentimark Device",
        "  Migration of the device>10mm between mammograms, clip position >40mm from target lesion",
        "  Time frame: 1-4 weeks from placement",
        "Results 1: ",
        "  Arm/Group Title: Sentimark Device Placement",
        "  Arm/Group Description: Sentimark device placed in women having mastectomy surgery",
        "  Sentimark: Placement of a metallic clip with paramagnetic properties for tumour localisation",
        "  Overall Number of Participants Analyzed: 28",
        "  Measure Type: Number",
        "  Unit of Measure: percentage of Magseed migrating >10mm  100"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/29 (0.00%)"
    ]
}